Torkel Gren, Recipharm and Anders Millerhovf, CTC Clinical Trial Consultants discuss the steps needed for drug formulation during first-in-human (FIH) trials, if regulatory approval is to be achieved.
For all the effort and investment drugs companies have put into improving business agility, the gap between vision and reality is glaring. This could be because companies have yet to transform R&D decision-making, says James Man, Kinapse.
Ben Jones, technical manager, global serialisation services at PCI Pharma Services, discusses the complex world of serialisation and what strategies pharma companies can implement.
Lab automation has come a long way since the days of industrial robots, with new advancements increasing efficiency between systems and workers. Peter Harris, HighRes Biosolutions, discusses how far the sector has moved and what the future holds.
In this interview, Simon Cole, sales executive at Atlantic Zeiser UK, points out why blockchain is gaining importance in track & trace systems, and what effects can be expected from Brexit.
Paras Kumar, senior specialist at The Smart Cube, examines the critical role that patent research has within the life sciences and pharmaceutical businesses beyond its traditional uses by the R&D and legal departments.
John Rush subject matter expert — HVAC, from specialist cleanroom design and construction provider BES, discusses strategies for designing more energy efficient cleanrooms.
Alyn McNaughton, technical director for Lonza Edinburgh, Lonza Pharma & Biotech discusses the requirements and regulations surrounding serialisation legislation.
